Éric Toussirot,Ewa Bertolini,Daniel Wendling
Éric Toussirot
Ankylosing spondylitis (AS) is a systemic inflammatory rheumatic disease responsible for back pain, stiffness and progressive loss of functional capacity with limited therapeutic options. Regular physical exercises together with the use of ...
Charalampos Papagoras,Paraskevi V Voulgari,Alexandros A Drosos
Charalampos Papagoras
Adalimumab, a fully humanized monoclonal antibody against tumor necrosis factor-alpha (TNFα), has been evaluated in various randomized placebo-controlled trials in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and juven...
Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature [0.03%]
关节内皮质类固醇在幼年特发性关节炎治疗中的安全性、有效性及其影响因素：文献综述
Alisa Carman Gotte
Alisa Carman Gotte
Intra-articular corticosteroid injection (IACI) has been used in the treatment of inflammatory arthritis in adults for over fifty years. Over the last two decades, IACI has become an important tool in the management of juvenile idiopathic a...
Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis [0.03%]
阿巴西普治疗类风湿性关节炎的疗效、安全性和耐受性评估研究摘要
Joseph R Lutt
Joseph R Lutt
The management of rheumatoid arthritis (RA) has undergone an impressive transformation over the past few decades. Further understanding of the pathophysiology of the disease process has resulted in the development of biologic agents that ta...
A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study [0.03%]
前列腺素E2通过抑制SERPINE1基因表达减轻人关节软骨细胞纤维化的体外实验研究
Kayo Masuko,Minako Murata,Naoya Suematsu et al.
Kayo Masuko et al.
Prostaglandin E2 (PGE2) is expressed in articular joints with inflammatory arthropathy and may exert catabolic effects leading to cartilage degradation. As we observed in a preliminary experiment that PGE2 suppressed the expression of SERPI...
Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis [0.03%]
微小多血管炎患者血清中巨噬细胞迁移抑制因子(MIF)水平升高
Hirohito Kanemitsu,Mizuho Matsunawa,Kuninobu Wakabayashi et al.
Hirohito Kanemitsu et al.
Objective: To test the hypothesis that macrophage migration inhibitory factor (MIF) is involved in the disease activity of systemic vasculitis. Methods: ...